Subscribe Sign In Register

Premium

Hedge Fund Titans Bet Big on Drugmaker Shire’s Success

John Paulson, Dan Loeb, and other prominent Investors move into an industry in flux.

By Bailey McCann
December 8, 2016
2016-autumn-bailey-mccann-inside-the-trade-medical-article-page.jpg
Illustration by Renaud Vigor.

For the past few years, Shire has been defined by two things: popular niche drugs and failed M&A.

To continue reading, subscribe now to Premium Journalism. Already a subscriber? login.

Lone Pine Capital Shire John Paulson Dan Loeb Suvretta Capital Management Marshall Wace Hedge Fund
Related
Illustration by II
Hedge Funds
Dan Loeb’s Third Point Shuffles Major Tech Holdings
Steve Taub
August 6, 2024
Dan Loeb (David Paul Morris/Bloomberg)
Hedge Funds
Why Dan Loeb’s Third Point Is Underperforming
Steve Taub
July 8, 2024
Brainstorm business meeting to discuss analysis of financial figures, graphs and growth charts of business investments to plan new business projects.
Sponsored
Hands-On Operational Improvement Key to Creating Alpha in the Middle Market